We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
BFA
826
Bragg Financial Advisors
North Carolina
$4.42M +$37.8K +1,201 +0.8%
First Eagle Investment Management
827
First Eagle Investment Management
New York
$4.38M -$197M -6,276,183 -98%
CI
828
Constellation Investments
Ohio
$4.37M +$86.2K +2,740 +2%
FAB
829
First American Bank
Illinois
$4.35M +$187K +5,943 +4%
YIA
830
YHB Investment Advisors
Connecticut
$4.35M +$79.3K +2,520 +2%
DG
831
Davidson & Garrard
Virginia
$4.32M +$278K +8,835 +7%
CIP
832
Convergence Investment Partners
Florida
$4.31M -$6.1M -194,040 -58%
SM
833
Stratton Management
Pennsylvania
$4.31M -$1.01M -32,215 -19%
OC
834
Oakworth Capital
Alabama
$4.29M +$493K +15,673 +13%
DHFB
835
Dixon Hubard Feinour & Brown
Virginia
$4.27M +$78.8K +2,506 +2%
BFO
836
Boston Family Office
Massachusetts
$4.27M +$25.9K +823 +0.6%
HIM
837
Hanlon Investment Management
New Jersey
$4.27M +$3.93M +125,077 +877%
SGCA
838
Steel Grove Capital Advisors
Tennessee
$4.26M -$149K -4,749 -3%
V
839
ValueWorks
New York
$4.25M -$163K -5,194 -4%
MA
840
Marshwinds Advisory
Georgia
$4.23M -$206K -6,553 -5%
HDIM
841
Hanson & Doremus Investment Management
Vermont
$4.23M +$83.5K +2,653 +2%
CIC
842
Crawford Investment Counsel
Georgia
$4.23M -$173K -5,510 -4%
CIM
843
CenturyLink Investment Management
Colorado
$4.21M -$24.4K -777 -0.6%
Mariner
844
Mariner
Kansas
$4.17M -$387K -12,297 -8%
ECM
845
Endurant Capital Management
California
$4.17M +$4.29M +136,282 New
CWM
846
Calamos Wealth Management
Illinois
$4.17M +$138K +4,388 +3%
SBWM
847
Sunflower Bank Wealth Management
Arizona
$4.17M -$139K -4,422 -3%
IWA
848
Intercontinental Wealth Advisors
Texas
$4.16M +$4.27M +135,676 New
ICOA
849
Investment Centers of America
North Dakota
$4.12M +$194K +6,164 +5%
LIM
850
Leavell Investment Management
Alabama
$4.12M +$147K +4,658 +4%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.